Skip to main content
Tech.euFundingExplorerBeta

Monograph Capital

Investor profile

Venture capital

Monograph Capital has backed 1 European tech company across 2 funding rounds between 2023 and 2025, joining rounds totalling €81M. Most active in Healthtech. Data as of Nov 2026.

Deals
2
distinct rounds
Companies
1
backed
Active span
2023–2025
3 yrs
Total round €
€81M
sum of rounds joined

Deals by year

distinct rounds / year
Monograph Capital — deals by year — interactive chart.
Data table
Monograph Capital — deals by year
20231
20251

Top sectors

by deals
Monograph Capital — top sectors — interactive chart.
Data table
Monograph Capital — top sectors
Healthtech2

Stages

by deals
Monograph Capital — stages — interactive chart.
Data table
Monograph Capital — stages
Series A2

Countries

by deals
Monograph Capital — countries — interactive chart.
Data table
Monograph Capital — countries
UK2

Co-investment network

shared rounds
Co-investment network — interactive chart.
Monograph Capital — 2 dealsMonograph CapitalBGF — 2 shared deals · click to openBGFLifeArc Ventures — 2 shared deals · click to openLifeArc VenturesBritish Patient Capital — 1 shared deals · click to openBritish Patient CapitalEli lilly and company — 1 shared deals · click to openEli lilly and companyGeneral Catalyst — 1 shared deals · click to openGeneral CatalystSolasta Ventures — 1 shared deals · click to openSolasta Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Maxion TherapeuticsUK2€81M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Maxion TherapeuticsSeries A€66M2025-03
Maxion TherapeuticsSeries A€15M2023-02
← Back to investors